Cargando…

Reclassification of Five BRCA1/2 Variants with Unknown Significance Using Complex Functional Study

PURPOSE: While BRCA1/2 genes are commonly investigated, variants of unknown significance (VUS) and variants with potential splice effect are still being detected and they represent a substantial challenge in genetic counseling and therapy. MATERIALS AND METHODS: Out of genetically tested 3,568 hered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bozsik, Anikó, Papp, János, Grolmusz, Vince Kornél, Patócs, Attila, Oláh, Edit, Butz, Henriett
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582465/ https://www.ncbi.nlm.nih.gov/pubmed/35167739 http://dx.doi.org/10.4143/crt.2021.1078

Ejemplares similares

PALB2 Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer
por: Butz, Henriett, et al.
Publicado: (2023)

Genome sequencing-based discovery of a novel deep intronic APC pathogenic variant causing exonization
por: Bozsik, Anikó, et al.
Publicado: (2023)

Application of Multilayer Evidence for Annotation of C-Terminal BRCA2 Variants
por: Butz, Henriett, et al.
Publicado: (2021)

Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients—Novel Variants from a Large National Center
por: Bozsik, Anikó, et al.
Publicado: (2020)

A common genetic variation in GZMB may associate with cancer risk in patients with Lynch syndrome
por: Grolmusz, Vince Kornél, et al.
Publicado: (2023)

Germline Structural Variations in Cancer Predisposition Genes
por: Pócza, Tímea, et al.
Publicado: (2021)

Challenging interpretation of germline TP53 variants based on the experience of a national comprehensive cancer centre
por: Butz, Henriett, et al.
Publicado: (2023)

Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification
por: Grolmusz, Vince Kornél, et al.
Publicado: (2021)

Case Report: A Novel Pathomechanism in PEComa by the Loss of Heterozygosity of TP53
por: Butz, Henriett, et al.
Publicado: (2022)

Publisher Correction: Whole genome sequencing resolves 10 years diagnostic odyssey in familiar myxoma
por: Pálla, Sára, et al.
Publicado: (2023)

Whole genome sequencing resolves 10 years diagnostic odyssey in familiar myxoma
por: Pálla, Sára, et al.
Publicado: (2023)

Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer
por: Madar, László, et al.
Publicado: (2023)

From a variant of unknown significance to pathogenic: Reclassification of a large novel duplication in BRCA2 by high‐throughput sequencing
por: van Luttikhuizen, Jana Lisa, et al.
Publicado: (2019)

MicroRNAs in endocrine tumors
por: Butz, Henriett, et al.
Publicado: (2019)

Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression
por: Butz, Henriett, et al.
Publicado: (2022)

Feasibility of Follow-Up Studies and Reclassification in Spinocerebellar Ataxia Gene Variants of Unknown Significance
por: Ghorbani, Fatemeh, et al.
Publicado: (2022)

Clinical significance of variants of unknown significances in BRCA genes
por: Choi, Min Chul
Publicado: (2019)

Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression
por: Grolmusz, Vince Kornél, et al.
Publicado: (2016)

Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes
por: Butz, Henriett, et al.
Publicado: (2021)

Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors
por: Krokker, Lilla, et al.
Publicado: (2021)

True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome
por: Kövesdi, Annamária, et al.
Publicado: (2019)

The Clinical Significance of Unknown Sequence Variants in BRCA Genes
por: Calò, Valentina, et al.
Publicado: (2010)

Wnt-Signaling Regulated by Glucocorticoid-Induced miRNAs
por: Butz, Henriett, et al.
Publicado: (2021)

Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach
por: Sarkadi, Balazs, et al.
Publicado: (2022)

High-throughput functional evaluation of BRCA2 variants of unknown significance
por: Ikegami, Masachika, et al.
Publicado: (2020)

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers
por: Ha, Hyeong In, et al.
Publicado: (2020)

The influence of BRCA variants of unknown significance on cancer risk management decision-making
por: Chern, Jing-Yi, et al.
Publicado: (2019)

Molecular genetic diagnostics of hypogonadotropic hypogonadism: from panel design towards result interpretation in clinical practice
por: Butz, Henriett, et al.
Publicado: (2020)

MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma
por: Turai, Peter Istvan, et al.
Publicado: (2021)

Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort
por: Liu, Yun, et al.
Publicado: (2021)

Rare Variants Associated with Arrhythmogenic Cardiomyopathy: Reclassification Five Years Later
por: Vallverdú-Prats, Marta, et al.
Publicado: (2021)

Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma
por: Sarkadi, Balazs, et al.
Publicado: (2021)

Circulating miRNA Increases the Diagnostic Accuracy of Chromogranin A in Metastatic Pancreatic Neuroendocrine Tumors
por: Kövesdi, Annamária, et al.
Publicado: (2020)

Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance
por: Langerud, Jonas, et al.
Publicado: (2018)

The braingraph.org database with more than 1000 robust human connectomes in five resolutions
por: Varga, Bálint, et al.
Publicado: (2021)

Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
por: Kim, Joo Heung, et al.
Publicado: (2021)

Predicting Ovarian/Breast Cancer Pathogenic Risks of Human BRCA1 Gene Variants of Unknown Significance
por: Lin, Hui-Heng, et al.
Publicado: (2021)

Three Dimensional Cell Culturing for Modeling Adrenal and Pituitary Tumors
por: Krokker, Lilla, et al.
Publicado: (2021)

Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine
por: De Paolis, Elisa, et al.
Publicado: (2023)

Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls
por: Park, Ji Soo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jae8j5cmp6daa6nobdgjupidns